Top Markets
Coin of the day
Hubei Biocause Pharmaceutical Co., Ltd. Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd.

000627
Rang in Aktien #9082
Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a... Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a multifaceted business. Its primary activities within China involve the provision of life and motor insurance policies. Additionally, the company is engaged in the pharmaceutical, chemical, and new energy fuel industries. Specifically, in the pharmaceutical field, it conducts contract research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediate compounds, and various drug forms such as tablets, granules, and capsules. Its chemical offerings include substances like dimethyl ether gas and a-chloropropionyl chloride. The firm also boasts an international presence, distributing its products to markets including the United States, the European Union, and other global locations.
Aktienkurs
$0.2219522
Zuletzt synchronisiert: 2025-09-11
Marktkapitalisierung
$1.10B
Veränderung (1 Tag)
0.04%
Veränderung (1 Jahr)
0.17%
Land
CN
Handel Hubei Biocause Pharmaceutical Co., Ltd. (000627)
EPS für Hubei Biocause Pharmaceutical Co., Ltd. (000627)
EPS zum September 2024 TTM: $-0.02
Laut den aktuellen Finanzberichten und dem Aktienkurs von Hubei Biocause Pharmaceutical Co., Ltd. beträgt das aktuelle EPS des Unternehmens (TTM) $-0.02. Am Ende des Jahres 2022 betrug das EPS $0.01 ein Rückgang im Vergleich zu dem EPS von 2021, das $0.03 betrug.
EPS-Verlauf von Hubei Biocause Pharmaceutical Co., Ltd. von 2000 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
2026 (TTM) $-0.02 -21.50%
2023 $-0.02 -226.90%
2022 $0.01 -48.76%
2021 $0.03 -19.60%
2020 $0.04 -58.44%
2019 $0.08 115.52%
2018 $0.04 -14.75%
2017 $0.05 -27.29%
2016 $0.06 128.88%
2015 $0.03 185.57%
2014 $0.01 -178.23%
2013 $-0.01 -985.71%
2012 0.00 -111.76%
2011 $-0.01 -471.88%
2010 0.00 -40.74%
2009 $0.01 -292.86%
2008 0.00 -122.58%
2007 $0.01 113.79%
2006 $0.01 625.00%
2005 0.00 33.33%
2004 0.00 -111.54%
2003 $-0.01 -966.67%
2002 0.00 -80.65%
2001 0.00 0.00%
2000 0.00 0.00%
EPS für ähnliche Unternehmen oder Wettbewerber